Streetbeat News

Analyst Ratings

PENN

Investors are showing a bullish stance on PENN Entertainment, with significant options trading activity. The sentiment is 64% bullish and 29% bearish, focusing on a price range of $15 to $25. PENN's stock is up 8.17% at $19.86, with an upcoming earnings announcement in 48 days.

Portfolio Pulse from Benzinga Insights

September 13, 2024 | 4:07 pm

SBSW

BMO Capital has maintained a Market Perform rating on Sibanye Stillwater (NYSE:SBSW) but has lowered the price target from $5 to $4.5.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 4:07 pm

EOLS

Evolus (NASDAQ:EOLS) has received diverse analyst ratings over the past three months, with a majority being bullish. The average 12-month price target has increased by 4.6% to $22.75. Analysts have adjusted their ratings and price targets, reflecting positive sentiment. Evolus, a performance beauty company, has shown strong revenue growth but faces challenges with high debt and low ROE and ROA.

Portfolio Pulse from Benzinga Insights

September 13, 2024 | 4:01 pm

IREN

Iris Energy (NASDAQ:IREN) has received mixed analyst ratings, with a majority being bullish. Analysts have set a 12-month average price target of $16.53, reflecting a slight increase from previous targets. The company's financial performance shows strong revenue growth and effective asset utilization, despite a negative net margin and ROE. Analysts have adjusted their ratings and price targets based on recent developments.

Portfolio Pulse from Benzinga Insights

September 13, 2024 | 4:01 pm

U

Unity Software (NYSE:U) has received mixed analyst ratings, with a recent decrease in average price target by 17.29%. Analysts have provided a range of price targets from $10.00 to $33.50. The company faces challenges with declining revenue, low net margins, and high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 13, 2024 | 4:01 pm

PK

Park Hotels & Resorts (NYSE:PK) has received mixed analyst ratings over the past three months, with a recent decrease in average price target by 12.64%. Analysts have lowered their price targets, reflecting a negative sentiment shift. Despite challenges in revenue growth, the company shows strong financial health with high net margin, ROE, and ROA, and a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 13, 2024 | 4:01 pm

ALGN

Align Tech (NASDAQ:ALGN) has been analyzed by 7 analysts, showing a range of perspectives from bullish to bearish. The average 12-month price target is $325, down 7.07% from the previous $349.71. Analysts have adjusted their ratings and price targets, reflecting evolving market conditions. Align Tech is a leading manufacturer of clear aligners, with strong financial metrics such as a high net margin and ROE, but its revenue growth lags behind industry peers.

Portfolio Pulse from Benzinga Insights

September 13, 2024 | 4:00 pm

NBIX

Neurocrine Biosciences' phase two trial of luvadaxistat for schizophrenia failed to meet its primary endpoint, leading the company to halt its development. Instead, Neurocrine will focus on advancing NBI-1117568 for schizophrenia and NBI-1065845 for major depressive disorder. Despite the setback, analysts maintain an Outperform rating on the stock, citing potential in other areas.

Portfolio Pulse from Vandana Singh

September 13, 2024 | 4:00 pm

CNO

CNO Financial Group (NYSE:CNO) has been analyzed by five analysts, showing a range of ratings from somewhat bullish to somewhat bearish. The average 12-month price target has increased to $33.2, reflecting an 8.5% rise. Analysts have adjusted their ratings and price targets, with some maintaining or raising their outlook. CNO's financial performance shows a 4.24% revenue growth, a strong net margin of 10.91%, and a high ROE of 4.85%, but challenges in asset utilization and debt management.

Portfolio Pulse from Benzinga Insights

September 13, 2024 | 4:00 pm

PINS

Piper Sandler analyst Thomas Champion has reiterated an Overweight rating on Pinterest (NYSE:PINS) and maintained a price target of $45.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 4:00 pm